title: MERS Vaccine Candidate Offers Promise, but Questions Remain.
authors.affiliation: Departments of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
authors.forename: Vineet D
authors.initials: VD
authors.lastname: Menachery
mesh_terms: D057134:Antibodies, Neutralizing / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology; D002162:Camelus / Q000276:immunology; D017934:Coronavirus / Q000276:immunology; D018352:Coronavirus Infections / Q000517:prevention & control; D018819:Dipeptidyl Peptidase 4; D006801:Humans; D065207:Middle East Respiratory Syndrome Coronavirus / Q000276:immunology; D064370:Spike Glycoprotein, Coronavirus / Q000276:immunology*; D014612:Vaccines; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D064370:Spike Glycoprotein, Coronavirus; D014612:Vaccines; D014765:Viral Vaccines; D018819:Dipeptidyl Peptidase 4
keywords: MERS-CoV; RBD; Vaccine